Cargando…

Albumin for End-Stage Liver Disease

Albumin has been widely used in patients with cirrhosis in an attempt to improve circulatory and renal functions. The benefits of albumin infusions in preventing the deterioration in renal function associated with large-volume paracentesis, spontaneous bacterial peritonitis, and established hepatore...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lee, June Sung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295983/ https://www.ncbi.nlm.nih.gov/pubmed/22403494 http://dx.doi.org/10.3904/kjim.2012.27.1.13

Ejemplares similares

Opportunistic infections in end stage liver disease
por: Bartoletti, Michele, et al.
Publicado: (2018)

Liver Regeneration and Cell Transplantation for End-Stage Liver Disease
por: Li, Yan, et al.
Publicado: (2021)

Important predictor of mortality in patients with end-stage liver disease
por: Kim, Hyung Joon, et al.
Publicado: (2013)

The Yin and the Yang of Hemostasis in End-Stage Liver Disease
por: Saner, Fuat H., et al.
Publicado: (2023)

Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure
por: Liao, Shengen, et al.
Publicado: (2021)

Effect of Sevelamer and Nicotinamide on Albumin Carbamylation in Patients with End-Stage Kidney Disease
por: Lenglet, Aurelie, et al.
Publicado: (2021)

Individualized Management of Coagulopathy in Patients with End-Stage Liver Disease
por: Tomić Mahečić, Tina, et al.
Publicado: (2022)

Cell therapy in end-stage liver disease: replace and remodel
por: Hu, Xin-Hao, et al.
Publicado: (2023)

Perioperative Management of Lactic Acidosis in End-Stage Liver Disease Patient
por: Vitin, Alexander A., et al.
Publicado: (2017)

Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management
por: Verbeek, Thomas A., et al.
Publicado: (2018)

Protective role of melatonin in early‐stage and end‐stage liver cirrhosis
por: Hu, Chenxia, et al.
Publicado: (2019)

Cardiovascular manifestation of end-stage liver disease and perioperative echocardiography for liver transplantation: anesthesiologist’s view
por: Han, Sangbin, et al.
Publicado: (2022)

Estimating Average Glucose Levels from Glycated Albumin in Patients with End-Stage Renal Disease
por: Kim, Jwa-Kyung, et al.
Publicado: (2012)

Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine
por: Lau, Tsang, et al.
Publicado: (2013)

Chronotropic incompetence in end-stage liver disease
por: Główczyńska, Renata, et al.
Publicado: (2022)

Effectiveness of adding a defibrillator with cardiac resynchronization therapy in heart failure according to the modified Model for End-stage Liver Disease-Albumin score
por: Cheng, Sijing, et al.
Publicado: (2023)

Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control
por: Gao, Yun, et al.
Publicado: (2022)

The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease
por: Alves, Filipa Caeiro, et al.
Publicado: (2018)

Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients
por: Li, Xiejia, et al.
Publicado: (2023)

Alteration of the QT variability index in end-stage liver disease
por: Huh, In Young, et al.
Publicado: (2014)

Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions
por: Righi, Elda
Publicado: (2018)

Mortality scoring systems for liver transplant recipients: before and after model for end-stage liver disease score
por: Chung, Yang-Hoon, et al.
Publicado: (2023)

Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation
por: Raza, Muhammad H., et al.
Publicado: (2023)

Cellular Senescence in Livers from Children with End Stage Liver Disease
por: Gutierrez-Reyes, Gabriela, et al.
Publicado: (2010)

High-dose hydroxocobalamin in end-stage liver disease and liver transplantation
por: Sakpal, Sujit Vijay, et al.
Publicado: (2019)

End of Life Care in End-Stage Kidney Disease
por: Prabhu, Ravindra Attur, et al.
Publicado: (2021)

Serum albumin and mortality in patients with HIV and end-stage renal failure on peritoneal dialysis
por: Ndlovu, Kwazi Celani Zwakele, et al.
Publicado: (2019)

GENDER DIFFERENCES IN DEPRESSIVE SYMPTOMS OF PATIENTS WITH END-STAGE LIVER DISEASE
por: Hiatt, Shirin O, et al.
Publicado: (2019)

THE USE OF MELD SCORE (MODEL FOR END-STAGE LIVER DISEASE) AND DERIVATIVES IN CARDIAC TRANSPLANTATION
por: de MORAES, Ana Claudia Oliveira, et al.
Publicado: (2018)

Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent
por: Kawai, Yasuhiro, et al.
Publicado: (2018)

Inventing Engineered Organoids for end-stage liver failure patients
por: Antarianto, Radiana D, et al.
Publicado: (2022)

Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease
por: Patel, Arpan, et al.
Publicado: (2020)

Correction: Cellular Senescence in Livers from Children with End Stage Liver Disease
por: Gutierrez-Reyes, Gabriela, et al.
Publicado: (2010)

DNA methylation profile of liver tissue in end-stage cholestatic liver disease
por: Cheung, Angela C, et al.
Publicado: (2022)

Bioengineered functional humanized livers: An emerging supportive modality to bridge the gap of organ transplantation for management of end-stage liver diseases
por: Vishwakarma, Sandeep Kumar, et al.
Publicado: (2018)

Human albumin in the management of complications of liver cirrhosis
por: Bernardi, Mauro, et al.
Publicado: (2012)

Prevalence of myocardial perfusion abnormalities in end-stage liver disease
por: Fathala, Ahmed, et al.
Publicado: (2011)

Stem cell transplantation for the treatment of end-stage liver disease
por: Wu, Dong-Bo, et al.
Publicado: (2018)

Refitting the Model for End‐Stage Liver Disease for the Eurotransplant Region
por: Goudsmit, Ben F. J., et al.
Publicado: (2021)

Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V(2)-Receptor Antagonist Tolvaptan
por: Gaglio, Paul, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3bu74pc0a616qb9c20k22dhiqn